Understand which barriers to cancer trial participation remain most difficult to overcome, including geography and trial ...

Companies looking to execute decentralized clinical trials should watch out for data variability and precision as information comes in from patients’ homes or local healthcare facilities, according to ...

Contract research organization Allucent has been chosen as a partner for the U.S. Biomedical Advanced Research and Development Authority’s new five-year program that aims to scale up the capacity for ...

Over the past few years, factors like the Covid-19 pandemic have accelerated the adoption of decentralized – or Virtual - clinical trials. This approach leverages advances in digital technologies, ...

Please provide your email address to receive an email when new articles are posted on . FDA issued guidance on decentralized elements of clinical trials last fall. Investigators need to balance using ...

Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

As we begin the new year, there is a lot of talk in the drug development world about Federal Drug Administration (FDA) guidance documents for clinical and decentralized clinical trials (DCTs). This ...

The continued maturation of decentralized clinical trials (DCTs) has given researchers the ability to securely collect real-world data on patients as they go about their daily routines. This broader ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT ...

(MENAFN- Navistrat Analytics) December 09, 2025- Growing demand for patient-centric clinical models is a major factor accelerating revenue in the decentralized clinical trials (DCT) market. DCTs are ...